JP2001524941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001524941A5 JP2001524941A5 JP1998531191A JP53119198A JP2001524941A5 JP 2001524941 A5 JP2001524941 A5 JP 2001524941A5 JP 1998531191 A JP1998531191 A JP 1998531191A JP 53119198 A JP53119198 A JP 53119198A JP 2001524941 A5 JP2001524941 A5 JP 2001524941A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/782,219 US6080383A (en) | 1997-01-13 | 1997-01-13 | Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer |
| US08/782,219 | 1997-01-13 | ||
| PCT/US1998/000511 WO1998030247A1 (en) | 1997-01-13 | 1998-01-13 | A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001524941A JP2001524941A (ja) | 2001-12-04 |
| JP2001524941A5 true JP2001524941A5 (enExample) | 2005-09-08 |
Family
ID=25125383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53119198A Pending JP2001524941A (ja) | 1997-01-13 | 1998-01-13 | 可溶性放射性有毒物質の酵素変換による、癌治療のための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US6080383A (enExample) |
| EP (1) | EP1047456A4 (enExample) |
| JP (1) | JP2001524941A (enExample) |
| AU (1) | AU5913198A (enExample) |
| WO (1) | WO1998030247A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7807136B2 (en) * | 1997-01-13 | 2010-10-05 | David S. Rose | Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer |
| US20030068382A1 (en) * | 1999-05-18 | 2003-04-10 | Samuel Rose | Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer |
| CA2322969A1 (en) * | 1998-03-20 | 1999-09-23 | Genzyme Corporation | Methods to provoke anti-cancer immune responses |
| US7514067B2 (en) | 2000-04-25 | 2009-04-07 | President And Fellows Of Harvard College | Methods for tumor diagnosis and therapy |
| US20030032675A1 (en) * | 2001-02-15 | 2003-02-13 | Franz G. Andrew | Manufacture of thyroid hormone tablets having consistent active moiety amounts |
| US7067148B2 (en) * | 2001-02-15 | 2006-06-27 | King Pharmaceutical Research & Development, Inc. | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
| US20030224047A1 (en) * | 2001-02-15 | 2003-12-04 | Franz G. Andrew | Levothyroxine compositions and methods |
| US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
| US6565537B2 (en) * | 2001-04-18 | 2003-05-20 | Dennis R. Tollini | Tube securing assembly |
| US20030180353A1 (en) * | 2001-08-10 | 2003-09-25 | Franz G. Andrew | Stabilized pharmaceutical compositions |
| US20030190349A1 (en) * | 2001-08-10 | 2003-10-09 | Franz G. Andrew | Methods of stabilizing pharmaceutical compositions |
| US20030198667A1 (en) * | 2001-08-10 | 2003-10-23 | Franz Andrew G. | Methods of producing dispersible pharmaceutical compositions |
| US20030198672A1 (en) * | 2001-08-14 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique triidothyronine plasma AUC properties |
| US20030203967A1 (en) * | 2001-08-14 | 2003-10-30 | Franz G. Andrew | Levothyroxine compositions having unique Tmax properties |
| US20030195253A1 (en) * | 2001-08-14 | 2003-10-16 | Franz G. Andrew | Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration |
| US20030199587A1 (en) * | 2001-08-14 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique Cmax properties |
| US20030199586A1 (en) * | 2001-08-14 | 2003-10-23 | Franz G. Andrew | Unique levothyroxine aqueous materials |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| US20030190350A1 (en) * | 2001-10-29 | 2003-10-09 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
| US7615221B2 (en) * | 2004-07-23 | 2009-11-10 | Oncologic, Inc. | Compositions and methods for treating cancer |
| WO2021215952A1 (ru) | 2020-04-24 | 2021-10-28 | Общество С Ограниченной Ответственностью "Индженик" | Способ получения частиц бактериофагов семейства levivirus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4189470A (en) * | 1973-01-30 | 1980-02-19 | Bio-Response, Inc. | Method for the continuous removal of a specific antibody from the lymph fluid in animals and humans |
| US3964467A (en) * | 1973-01-30 | 1976-06-22 | Bio Response Inc. | Methods and apparatus for augmentation of the production of anti-bodies in animals and humans and the collection thereof |
| CA1041445A (en) * | 1973-04-09 | 1978-10-31 | Sam Rose | Method and apparatus for continuous mass in vitro suspension culture of cells |
| EP0109861A3 (en) * | 1982-11-23 | 1986-05-14 | Bio-Response Inc. | Method for isolating cells |
| IN165717B (enExample) * | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
| US4861581A (en) * | 1986-12-05 | 1989-08-29 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
| US5589328A (en) * | 1994-08-04 | 1996-12-31 | Mahant; Vijay K. | Chemiluminescence assays based on indoxyl substrates, thioindoxyl substrates and other substrates |
-
1997
- 1997-01-13 US US08/782,219 patent/US6080383A/en not_active Expired - Fee Related
-
1998
- 1998-01-13 WO PCT/US1998/000511 patent/WO1998030247A1/en not_active Ceased
- 1998-01-13 AU AU59131/98A patent/AU5913198A/en not_active Abandoned
- 1998-01-13 EP EP98902485A patent/EP1047456A4/en not_active Withdrawn
- 1998-01-13 JP JP53119198A patent/JP2001524941A/ja active Pending
-
1999
- 1999-05-18 US US09/314,422 patent/US6468503B2/en not_active Expired - Fee Related